1. Hydroxyurea in Sickle Cell Disease and Invasive Bacterial Infections: A Case-Control Study.
- Author
-
Pascault A, Koehl B, Brousse V, Benkerrou M, and Gaschignard J
- Subjects
- Humans, Case-Control Studies, Child, Female, Male, Adolescent, Child, Preschool, Anemia, Sickle Cell complications, Anemia, Sickle Cell drug therapy, Hydroxyurea therapeutic use, Hydroxyurea adverse effects, Antisickling Agents therapeutic use, Antisickling Agents adverse effects, Bacterial Infections drug therapy
- Abstract
Hydroxyurea decreases painful events among children with sickle cell disease (SCD) but could increase the risk of infections in treated patients through leucopenia. We performed a case-control study, comparing hydroxyurea treatment for SCD in cases with an invasive bacterial infection and in controls without infection. No difference was found., (© The Author(s) 2024. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF